Tango Therapeutics (TNGX) Assets Average (2020 - 2026)

Tango Therapeutics' Assets Average history runs 7 years deep, the most recent figure standing at $417.2 million for Q1 2026.

• On a quarterly basis, Assets Average rose 41.25% year-over-year to $417.2 million in Q1 2026; TTM through Mar 2026 was $417.2 million, a 41.25% increase from a year earlier, with the FY2025 full-year figure at $357.6 million, down 0.54% from the prior year.
• Assets Average climbed to $417.2 million in Q1 2026 per TNGX's latest filing, from $304.4 million in the prior quarter.
• Across five years, Assets Average topped out at $485.8 million in Q1 2022 and bottomed at $224.0 million in Q3 2025.
• The 5-year median for Assets Average is $403.8 million (2023), against an average of $381.2 million.
• Across the five-year window, Assets Average soared 173.94% in 2022 and tumbled 38.95% in 2025, its largest moves.
• Year by year, Assets Average stood at $450.3 million in 2022, then fell by 7.76% to $415.4 million in 2023, then dropped by 19.48% to $334.5 million in 2024, then decreased by 8.98% to $304.4 million in 2025, then jumped by 37.06% to $417.2 million in 2026.
• Per Business Quant, the three latest TNGX Assets Average figures stand at $417.2 million (Q1 2026), $304.4 million (Q4 2025), and $224.0 million (Q3 2025).